Photodynamic therapy-mediated immune response against subcutaneous mouse tumors

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1941-1946

  Korbelik, Mladen ^a,c   Dougherty, Graeme J ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PHOTODYNAMICS; PRIORITY JOURNAL; SARCOMA; TREATMENT OUTCOME; TUMOR GROWTH;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, SCID; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS; SPLEEN; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED;

EID: 0033561534     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst., 90: 889-905, 1998.
2. Korbelik, M. Induction of tumor immunity by photodynamic therapy. J. Clin. Laser Med. Surg., 14: 329-334, 1996.
3. Gomer, C. J., Luna, M., Ferrario, A., Wong, S., Fisher, A. M. R., and Rucker, B. S. Cellular targets and molecular responses associated with photodynamic therapy. J. Clin. Laser Med. Surg., 14: 315-321, 1996.
4. Ryter, S. W., and Gomer, C. J. Nuclear factor κB binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochem. Photobiol., 58: 753-756, 1993.
5. Kick, G., Messer, G., Goetz, A., Plewig, G., and Kind, P. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-κB DNA binding. Cancer Res., 55: 2373-2379, 1995.
6. Gollnick, S. O., Liu, X., Owczarczak, B., Musser, D. A., and Henderson, B. W. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res., 57: 3904-3909, 1997.
7. Anderson, C., Hrabovsky, S., McKinley, Y., Tubesing, K., Tang, H., Dunbar, R., Mukhtar, H., and Elmets, C. A. Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression. Photochem. Photobiol., 65: 895-901, 1997.
8. Nseyo, U. O., Whalen, R. K., Duncan, M. R., Berman, B., and Lundahl, S. L. Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. Urology, 36: 167-171, 1990.
9. De Wree, W. J., Essers, M. C., Koster, J. F., and Sluiter, W. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res., 57: 2555-2558, 1997.
10. Cuenco, G. M., Knisely, T. L., Averboukh, L., Garett, L., Castro, S., and Cincotta, A. H. Induction of glucose regulatory proteins in tumor cells after treatment a benzophenothiazine analogue. Photochem. Photobiol., 65: 19S, 1997.
11. Korbelik, M., Krosl, G., Krosl, J., and Dougherty, G. J. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res., 56: 5647-5652, 1996.
12. Rockwell, S. C., Kallman, R. F., and Fajardo, L. F. Characteristics of a serially transplanted mouse mammary tumor and its tissue culture-adapted derivative. J. Natl. Cancer Inst., 49: 735-749, 1972.
13. Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A. Antigenic properties of chemically induced tumors. Ann. NY Acad. Sci., 101: 80-106, 1962.
14. Lord, E. M. Factors influencing tumor cell immunogenicity. In: R. F. Kallman (ed.), Rodent Tumor Models in Experimental Cancer Therapy, pp. 23-26. New York: Pergamon Press, 1987.
15. Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K., and Tamaoki, N. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol., 127: 34-38, 1981.
16. Gollnick, S. O., Musser, D. A., and Henderson, B. W. Photodynamic therapy affects the expression of IL-6 and IL-10 in vivo. Conference on Laser-Tissue Interaction IX, International Biomedical Optics Symposium BiOS '98, San Jose, CA, January 24-30, 1998.
17. Bosma, M. J., and Carroll, A. M. The SCID mouse mutant: definition, characterization and potential use. Annu. Rev. Immunol., 9: 323-350, 1991.
18. Ville, R. G., and Hart, I. R. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res., 53: 3860-3864, 1993.
19. Mullen, C. A., Coale, M. M., Lowe, R., and Blaese, R. M. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res., 54: 1503-1506, 1994.
20. Shu, S., Plautz, G. E., Krauss, J. C., and Chang, A. E. Tumor immunology. J. Am. Med. Assoc., 278: 1972-1981, 1997.
21. Korbelik, M., and Cecic, I. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett., 137: 91-98, 1999.
22. Kagamu, H., Touhalisky, J. E., Plautz, G. E., Krauss, J. C., and Shu, S. Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes. Cancer Res., 56: 4338-4342, 1996.
23. Area, M. J., Krauss, J. C., Aruga, A., Cameron, M. J., Shu, S., and Chang, A. E. Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor. Cancer Gene Ther., 3: 39-47, 1996.
24. Chiang, C. S., Syljuasen, R. G., Hong, J. H., Wallis, A., Dougherty, G. J., and McBride, W. H. Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo. Cancer Res., 57: 3899-3903, 1997.
25. Korbelik, M., and Sun, J. Cancer treatment by photodynamic therapy combined with NK cell line based adoptive immunotherapy. SPIE Proc., 3254: 4-11, 1998.